Bacterial infections are caused by pathogenic bacteria that invade the body, leading to a wide range of illnesses. Bacteria are single-celled microorganisms that can be both beneficial and harmful. Infections can occur in various parts of the body, affecting the respiratory system, gastrointestinal tract, skin, urinary tract, and more. Common bacterial infections include strep throat, urinary tract infections, pneumonia, and bacterial gastroenteritis. Symptoms can vary but often include fever, pain, inflammation, and other signs of localized or systemic illness. Bacterial infections are typically treated with antibiotics, which are medications specifically designed to target and eliminate bacteria. However, overuse or misuse of antibiotics can contribute to antibiotic resistance, a global health concern. Preventive measures for bacterial infections include practicing good hygiene, such as handwashing, proper food handling, and vaccinations. Immunizations against bacterial pathogens have been instrumental in preventing serious bacterial diseases. While many bacterial infections can be effectively treated with antibiotics, some may become chronic or recurrent, requiring ongoing management. Timely diagnosis and appropriate treatment are crucial for addressing bacterial infections and preventing complications.
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Nanoscopic SubATVax™ adjuvanted vaccines against influenza A types H3N2, H1N1 and influenza type B for subcutaneous administration
David Craig Wright, D4 Labs, LLC, United States
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : Commensal bacteria drive B-cell lymphomagenesis in the setting of innate immunodeficiency
Ping Xie, Rutgers University, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy